Skip to main content
. 2015 Apr 28;10(4):e0125367. doi: 10.1371/journal.pone.0125367

Table 2. Differentially expressed copper-binding proteins identified by MS/MS.

Spot no. a ) Fold-ch. b ) 39/95 NCBI Acc.no. c ) Protein name Mr/PI SC d ) (%) Score PM e ) MS/MS peptide sequence >95% C.I. (Indv. ion score)
Theoretical Observed
Proteins involved in antioxidation and detoxification
5 4.41/3.88 a/b AAG46133 Putative peroxidase 35.4/7.55 42.1/5.16 5 130 1(1) GLDAEDMVVLSGAHTVGR(130)
22 2.4/3.2 b/a AAC04837 Germin-like protein 6 24.5/5.92 26.6/6.54 28 388 6(5) AAMLDTPR(42); YVNADHFFK(57); HSPVLVNGFACLDPK (98); IDYAPLGENPPHTHPR(120); GTIDWLQAQFWENNHY(71)
28 2.5/2.1 a/a BAB92583 Putative quinone-oxidoreductase(QR2) 21.7/6.06 23.3/6.36 48 392 6(6) VYVVYYSMYGHVAK(74); IWQVPETLHEEVLGK(83); WP TEMELEHAFHQGK(36); MFNMGEVQGGSPYGAGTFAAD GSR(109); MGAPPKPDVPTITPQELTEADGILFGFPTR(90)
29 2.7/1.1 a/b- Q7XUP7 Methionine sulfoxide reductase A2-1 21.1/5.88 21.5/5.99 35 472 8(5) HNPTTLNR(55); IVTEILPATR(62); TEVGYSQGHR(77); FYPAEEYHQR(65); DVCGGGTGHAEVVR(137)
33 1.2/4.6 b/a AAA33917 Copper/zinc superoxide dismutase 15.3/5.71 17.7/6.29 15 175 2(2) EHGAPEDETR(76); AVVVHADPDDLGK(99)
16 3.8/1.8 a/b AAC64007 Glutathione S-transferase II 24.3/5.77 24.8/5.47 37 479 6(6) VVEENLEK(65); VLEVYEAR(71); GEHKAPDHLAR(60); LYGSTLSWNVTR(91); NPFGQVPALQDGDLFLWESR(90); CVAVLEEAGAEYEIVPLDFSK(101)
21 3.3/1.5 a/b AAC64007 Glutathione S-transferase II 24.3/5.77 26/6.3 27 358 5(5) VVEENLEK(65); VLEVYEAR(75); GEHKAPDHLAR(50); LYGSTLSWNVTR(100); CVAVLEEAGAEYEIVPLDFSK(68)
Proteins involved in transcriptional regulation
8 2.32/1.72 a/b BAC65369 CHP-rich zinc finger protein-like 28.4/4.95 32.9/4.75 23 326 5(4) DHDMKER(41); KMEDDFDAFTASK(75); IAIAVDLSDESA YAVR(117); LGSVSDYCVHHCVCPVVVVR(71);
34 new/none BAC66711 Putative cold shock protein-1 19.0/6.28 17.9/6.51 74 704 8(7) GYGGGGGGYGGGDR(87); GYGGGGGYGGGGGGGS R(107); DCSQGGGGGGGYGGGGGGYR(136); SLNDGDVV EFSVGSGNDGR(138); GGGGGGGGGGCYNCGETGHI AR(102); AVDVTAPGGGALTGGSRPSGGGDR(45); GFGF ITPDDGGEDLFVHQSSLK(62)
Proteins involved in protein synthesis, modification, transport and degrdation
30 0.57/0.01 a/b ABA98689 Putative eukaryotic translation initiation factor 5A-2 17.8/5.6 17.6/5.9 45 364 5(5) TYPQQAGTIR(59); LPTDDNLLSQIK(99); CHFVAIDIFT AK(102); DLVVTVMSAMGEEQICALK(38); KLEDIVPSS HNCDVPHVNR(68)
31 0.14/0.6 b/a ABF98987 Putative eukaryotic translation initiation factor 5A-2 17.9/5.87 17.0/6.0 40 270 6(4) NGHIVIK(37); TYPQQAGTIR(62); CHFVAIDIFNGK(79); DDLRLPSDEALLTQIK(43);
32 0.57/0.02 a/b AAC67555 Translation initiation factor 5A 17.7/5.77 16.8/6.2 35 479 6(6) TYPQQAGTIR(57); LPTDDSLLGQIK(84); CHFVAIDIFN GK(92); DDLRLPTDDSLLGQIK(54); LEDIVPSSHNCDVPHV NR(94); KLEDIVPSSHNCDVPHVNR(100)
19 0.89/0.47 a-/b BAD26337 Putative elongation factor EF-2 94.9/5.85 42.2/6.55 10 423 7(6) GGGQVIPTAR(41); VIYASQLTAKPR(73); RVIYASQLTAKPR(56); ILSEEFGWDKDLAK(81); AYLPVIESFGFSSQLR(103); GHVFEEMQRPGTPLYNIK(46)
4 1.57/1.52 a/a AAX85991 Protein disulfide isomerase 57.05/4.95 71.5/4.9 18 466 8(7) NIQEYKGPR(40); GDAAVERPLVR(37); TADEIVDFIK K(64); VVVADNVHDFVFK(104); AHVEPDQIVSWLK(88); SDYDFGHTLHANHLPR(50); VVTFDKNPDNHPYLLK(56)
35 new/none ABA99827 Putative ubiquitin-conjugating enzyme spm2 16.8/6.42 16.5/6.52 46 292 6(4) FSLLSNWR(39); EYTMEAILTQLKK(81); LFCDKDYPDRPPTVK(53); SWTGTIIGPHNTVHEGR(59)
15 1.7/1.1 a/b- BAA94966 Epsilon-COP 1 31.7/5.23 27.5/5.18 32 551 6(6) AVSAEDNFER(68); LSHPDHVLVK(48); EAYLIFQDFAE K(94); EWLSDSAVGSNPVLR(119); LIAGIIFMHEQDYTEA LK(112); NLFYLGAYQAAINNSDVPGLDADAAAER(109)
10 3.23/2.23 a/b AAX11351 Cathepsin B-like cysteine protease 40.4/6.25 30.9/5.11 23 550 8(8) HFSVNAYR(66); GWGDDGYFK(62); KHFSVNAYR(61); HITGGMMGGHAVK(78); PGCEPAYPTPVCEK(90); GTNEC GIEEDVVAGMPSTK(99); GVVTDECDPYFDQVGCK(93)
1 2.21/2.34 a/a P25776 Oryzain alpha chain; Flags: Precursor 51.3/5.14 43.1/4.2 15 563 6(6) SWGESGYVR(61); CGIAVEPSYPLK(71); AFQLYSSGIFTGK (102); CGIAVEPSYPLKK(70); AVANQPVSVAIEAGGR(99); CGTALDHGVAAVGYGTENGK(159)
2 2.28/2.07 a/a P25776 Oryzain alpha chain; Flags: Precursor 51.3/5.14 42.1/4.24 8 222 3(3) SWGESGYVR(42); AFQLYSSGIFTGK(88); AVANQPVSVAIEAGGR(93)
Pathogenesis-related protein
23 1.8/none a/ BAC56823 Putative pathogenesis- related protein 18.2/4.76 19.6/4.25 20 220 3(3) STTSIGCAR(37); ADYVYSSNTCTR(72); GALLDCGH YTQVVWR(111)
26 new/none BAC56830 putative pathogenesis-related protein 19.4/4.37 11.7/4 41 216 4(3) AGDCALIHSGSWEK(94); RVEGVGEVVWDDAVAA YAENYAAER(37); VDCDNGGVFITCNYNPAGNFQG ERPFER(54)
25 7.5/2.3 a/b ABA99548 Pathogenesis-related protein Bet v I family protein 17.2/4.96 16.9/4.99 63 711 7(7) AVAVSVER(55); APAFVSDER(94); VCLDVHSLPK(69) IVVCDSATHVLK(76); SHSTETKLEATGDATCVAK (158); LTVEYELEDGASLSPEQEK(149); VCAGFIDA VEVEGNGGPGTIHIMK(109)
24 17.3/none a/ AAF85972 Pathogenesis-related protein PR-10a 16.9/4.95 14.2/4.81 18 165 2(2) VAVCDAASHVLK(55); APACVSDEHAVAVSAER(109)
Proteins involved in amino acid synthesis
6 2.35/5.81 b/a P14656 Glutamine synthetase shoot isozyme 39.4/5.51 40.8/5.32 13 407 5(5) DIVDSHYK(60); NDGGYEIIK(74); EHISAYGEGNE R(70); HKEHISAYGEGNER(104); HETADINTFSWG VANR(99);
11 0.34/none a/ P14656 Glutamine synthetase shoot isozyme 39.4/5.51 31.5/5.27 13 250 5(5) DIVDSHYK(67); NDGGYEIIK(72); EHISAYGEGN ER(91); HKEHISAYGEGNER(105); IIAEYIWIGGSG MDLR(49)
12 0.13/none a/ AAN05339 Putative glutamine synthetase root isozyme 38.8/5.73 33/5.36 17 456 6(5) DIVDAHYK(63); GPITDVSQLPK(81); EHIAAYGEGNE R(86); HKEHIAAYGEGNER(103); IIAEYIWVGGSGID LR(109)
Protein involved in cell wall synthesis
14 2.3/1.1 a/b- BAA81774 Putative caffeoyl-CoA O-methyltransferase 1 27.9/5.11 27.5/5.13 38 570 8(6) YVLDTTVLPR(59); YHEQLLQLVR(74); ESYEIGRPFL EK(51); GLEKLDELLAEEAAAGR(112); IDVCQLAIAD GITICR(119); EAAFDFAFVDADKPNYVK(108)
Protein involved in signal molecular
3 2.20/0.67 a/b- BAA88900 Calcium-binding protein 48.07/4.52 40.3/4.56 18 469 7(6) KVHTIFTK(56); NDKNHLIK(49); TLVLQFSVK(43); HEQKLDCGGGYVK(118); QSGSIYEHWDILPPK(89); FYAISAEYPEFSNKDK(91)
Proteins induced by salt stress
7 5.32/5.22 a/a AAB53810 Salt gene product 15.2/5.0 31.8/4.67 45 517 5(5) LLGVTIYSSDAIR(90); SGTLIDAIGIYVHP(106); KLL GVTIYSSDAIR(110); EFSIPLQDSGHVVGFFGR(84); EISGTHGPVYDLADIVTYLK(126);
27 new/none AAB53810 Salt gene product 15.2/5 9.2/5.04 51 506 6(5) LLGVTIYSSDAIR(102); SGTLIDAIGIYVHP(108); KLL GVTIYSSDAIR(93); EFSIPLQDSGHVVGFFGR(92); EISGTHGPVYDLADIVTYLK(103)
9 5.61/5.17 a/a A2WPN7 Salt stress-induced protein 15.2/5 33.1/5 66 656 6(6) LLGVTIYSSDAIR(118); SGTLIDAIGIYVHP(108); KLL GVTIYSSDAIR(113); EFSIPLQDSGHVVGFFGR(118); EISGTHGPVYDLADIVTYLK(121); SIAFNYIGVDGQ EYAIGPWGGGEGTSTEIK(79)
The other proteins
18 2.9/2.1 a/b BAC83197 Putative glyoxylate induced protein 34.2/5.98 31.1/6.43 30 515 7(7) DVNRDPLI(42); QPLLETPGEVFELR(102); HSVISDE VTTLVIFER(132); YTTIEGYHPDLIVGSTDK(44); A TNPTLAPAHLQDLPGFTR(68); RYTTIEGYHPDLIVG STDK(36); EVHYNQHGLLLLEGQGIYR(90)
20 2.8/3.3 b/a NP_001060247 Protein containing dimeric alpha-beta barrel domain 26.5/7.11 25.5/6.01 16 373 4(4) VSFGENFSPAR(82); LKEGVEAHQLAEK(89); SPAA EALGPTHVLHSR(117); LRSPAAEALGPTHVLHSR(85)
13 1.1/0.21 a-/b AAO72629 Adenosine kinase-like protein 40.6/5.57 37/5.45 35 780 8(8) KPENWALVEK(79); HLPMYDELASK(66); AGCYAAN VIIQR(82); GNVEYIAGGATQNSIR(155); VRGWETE NVEEIALK(76); VLPFVDYIFGNETEAR(115); IAVIT QGADPVVVAEDGQVK(128); NAQAAGVTAHYYEDE AAPTGTCAVCVVGGER(79)

Note: Differentially expressed copper-binding proteins identified by MS/MS.;

a Spot no., numbering corresponds to the 2-DE gel;

b Fold-ch., Fold-changes, the fold-changes of each spot was calculated by %Vol in treated samples/%Vol in control samples;

, up-regulated;

, down-regulated;

-, no change;

c Acc. no., accession number in NCBI database;

d SC, sequence coverage by MS/MS;

e PM, number of peptides matched;

The a and b of letter about fold-changes indicate a statistically significant difference (p≤0.05) between B1139 and B1195 by Duncan’s test.